Pertussis toxin (PTX) is the primary component responsible for eliciting the majority ofbiological activities associated with Bordetella pertussis, including the induction of several tissue-adjuvant models of organ-specific autoimmune disease. PTX, when administered in vivo, enhances vascular permeability, which is made manifest by a concomitant increase in sensitivity to a variety of agents and treatments affecting the vascular bed. One such agent is histamine, and the response to PTX, as measured by hypersensitivity following vasoactive amine challenge, is genetically controlled by the Bphs locus. Susceptibility to the induction of both experimental allergic encephalomyelitis (EAE) and experimental allergic orchitis (EAO) in mice is associated with, and in the latter case linked to, a susceptible allele at this locus. We report here the mapping of the Bphs locus to mouse chromosome 6, telomeric of Tcrb and centromeric of Prp (D6Nds8). This region also contains a number of loci of immunologic relevance including Igk, Ly-2, Ly-3, ll-5r, Ly-35, Ly-4, and Tnfr-2.
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Multiple sclerosis (MS) is the major inflammatory disease of the central nervous system (CNS). Both environmental and genetic factors contribute to what is believed to be primarily an immunopathologic etiology (1) . CNS vascular permeability (VP) changes have been implicated in both MS and its primary animal model, experimental allergic encephalomyelitis (EAE) (1) (2) (3) . Recent magnetic resonance imaging studies indicate that increased CNS-VP is a common feature in the brains of MS patients, even during clinically stable periods, and that both the development of new lesions and the enlargement of preexisting lesions appear to be due to a breakdown in the blood-brain barrier (BBB) (4) . Such studies support the concept that a pivotal event in lesion formation is an increase in CNS-VP, yet to date the initiating mechanisms that lead to such events in MS and EAE remain ill-defined.
Environmental factors including antecedent infections can alter the permeability of the BBB and even lead to the potentiation of EAE (5) . In this regard, Bordetella pertussis is particularly important. Normal mice injected with B. pertussis exhibit changes in BBB permeability (6) , and both pertussis vaccine and pertussis toxin (PTX) are used as ancillary adjuvants in the induction ofactive EAE in mice and rats (7, 8) . B. pertussis and PTX are capable of eliciting disease alone, without the use of other adjuvants (7, 8) . Disease induction is a function of both its immunopotentiating and vasoactive amine-sensitizing activities (7, 8) . The latter phenotype is manifest as death due to hypotensive and hypovolemic shock following vasoactive amine challenge of PTX-treated animals and is controlled by a single autosomal dominant non-H-2-linked gene (9, 10) , the B. pertussisinduced histamine-sensitization locus (Bphs). Susceptibility to the induction of EAE (11) and experimental allergic orchitis (EAO) in mice (12) is associated with, and in the latter case linked to, a susceptible allele at the Bphs locus.
The Bphs locus is also unique in its pleiotropic nature. PTX-treated mice with a susceptible Bphs allele also exhibit hypersensitivity to a variety of other agents and treatments that affect the vascular bed. These include infections, endotoxins, x-irradiation, anoxia, cold stress, peptone, bradykinin, methacholine, and serotonin (13, 14) .
The association of the Bphs locus with organ-specific autoimmune disease and the pivotal role of VP in both CNS immunology and inflammation in general (15) make its identification of primary importance in helping to define a key pathway in the pathophysiology of such responses. With the development of simple sequence length polymorphisms (SSLP) or microsatellites (16, 17) and random amplified polymorphic DNA (RAPD) fragments (18) , both of which show DNA variations between inbred strains of mice, it is now feasible to localize the genes controlling even complex traits to specific chromosomal regions (19, 20) . This approach may reveal linkage to candidate genes that can be sequenced or it may provide the first step in the positional cloning of the gene of interest. Using microsatellite and RAPD marker loci distributed across the mouse genome, we have mapped the Bphs locus distal to Tcrb and proximal to Prp (D6Nds8) on murine chromosome 6.
MATERIALS AND METHODS Animals. Male and female SJL/J, C3H/HeJ, and CBA/J mice ranging in age from 4 to 6 weeks were purchased from The Jackson Laboratory. All animals were rested 2 weeks (16, 17, 19, 20) . RAPD primers were purchased from Operon Technologies (Alameda, CA). An allele-specific primer set was designed to detect the presence of the SJL/ J-derived allele of the T-cell receptor (Tcr) p3-chain gene (Tcrb) called "Tcr-V,f3Oa" (23) in the backcross 1 (BC1) mice. The 5' primer (GAGCAAACCCTGGACCAC), when used with the 3' primer common to both alleles (TGGCA-CAGAGATACACAG), amplifies a 205-base-pair product from Tcr-Vf310a homozygotes or heterozygotes but will not produce a PCR product from Tcr-Vf3lOb homozygotes. Both primers were synthesized at the Hahnemann University Oligonucleotide Synthesis Facility.
Amplification Conditions and Detection of PCR Products. PCR parameters for microsatellite typing were performed as described (16, 17, 19, 20) . Both the efficiency and specificity of the PCRs were optimized by titrating primer pairs against various Mg2+ concentrations, annealing temperatures, and amplification cycles as described (16, 17, 19, 20 RAPD reactions were carried out as described (18) . Amplification was performed on a Techne model MW-1 Dri-Plate Cycler programmed for 45 cycles of94°C for 1.5 min, 33°C for 2.0 min, and 72°C for 2.5 min. Reaction products were resolved by electrophoresis at 75 V for 4 hr in a 2.5% ME-agarose (SeaKem, FMC) gel containing 1 x TAE buffer (18) and visualized with ethidium bromide.
The temperature-time cycle for the Tcr-V,B10 allelespecific PCR reactions was 94°C for 1 min, 55°C for 2 min, and 72°C for 2 min for 25 cycles on a Techne MW-1 Dri-Plate cycler. PCR-amplified products were separated on 6% acrylamide gels and detected by staining with ethidium bromide.
Linkage Analysis. Genotype frequency differences were tested by x2 in 2 x 2 contingency tables. The maximum likelihood genetic map of chromosome 6 as well as the maximum likelihood positional estimate of the Bphs locus was performed with the MAPMAKER program (24) .
RESULTS AND DISCUSSION SJL/J, C3H/HeJ, CBA/J, F1 hybrid, and BC1 populations were examined for their susceptibility to PTX-induced histamine sensitization (Table 1) . Groups of male and female SJL/J, C3H/HeJ, CBA/J, and F1 hybrid mice, ranging in age from 6 to 8 weeks, were challenged with 1.0 mg of histaminefree base 3 days after the injection of PTX; mice treated with carrier on day 0 served as controls. SJL/J mice and both F1 hybrid populations clearly exhibited increased sensitivity to histamine after PTX treatment (Table 1) . No significant difference was observed between male and female mice, indicating a lack of sex-linked influence. In contrast, neither C3H/HeJ nor CBA/J mice exhibited an increase in death due to hypotensive and hypovolemic shock after PTX pretreatment and histamine challenge. Carrier-treated parental strains and both F1 hybrid populations also failed to exhibit sensitivity after histamine challenge, as expected.
Our results are consistent with previously published observations that SJL/J mice are highly susceptible to PTXinduced histamine sensitization. In fact, SJL, SWR, and CFW serve as the three susceptible prototype strains, while C3H/HeJ and CBA/J are their resistant counterparts (9-11, 13, 14, 25) . Conflicting results have been reported for the majority of other mouse strains (9) (10) (11) 25) . Factors that contribute to the varying results observed among different laboratories include the route of injection of both PTX and histamine challenge, the preparation of pertussis vaccine or PTX or both, the environmental status of the animals, infectious agents, and the age of the mice (13, 14) . With regard to the latter, DBA/2J mice have been reported by Linthicum and Frelinger (11) and Teuscher (12) to be resistant to histamine sensitization, whereas Bergman and Munoz (25) and Wardlaw (9) have found them to be susceptible. (9, 10) .
To map the Bphs locus within the murine genome, we generated a molecular-based linkage map using both the C3H/HeJ and CBA/J BC1 populations. Previously mapped microsatellites (16, 17, 19, 20) and RAPD markers (18) (Fig. 1A) . In contrast, the CBA/J BC1 data place Bphs more distal, with the maximum lod score (12. 3) atPrp (D6Nds8). However, the interval can be extended centromeric to also include D6Nds2 (Lod = 11.2), since little difference exists between the two lod scores. The C3H/HeJ BC1 results are supported by the composite map generated from the combined BC1 data, which clearly localize Bphs between D6Nds3 and D6Nds2. Although the maximum likelihood estimate localizes Bphs between D6Nds3 and D6Nds2, the data are also consistent with placement within an expanded interval between Tcrb and Prp (D6Nds8). Additional animals and markers will be required to refine the support interval.
Our aim is to identify and characterize the non-majorhistocompatibility complex genes that influence susceptibility to a number of tissue-adjuvant models of organ-specific autoimmune disease. The Bphs locus is a prime candidate because it has been associated with susceptibility to EAE (11) and linked to EAO (12) . In addition to its utility in inducing organ-specific autoimmune disease, B. pertussis exhibits a broad range of immunopotentiating activities that make it a useful adjuvant (8) . PTX is capable of markedly stimulating antibody production, particularly IgE (14, 33) and also stimulating, augmenting, and prolonging antigen-specific delayed-type hypersensitivity reactions (8, 34) . This effect is antigen specific and mediated by CD4+ T cells. PTX also has been shown to greatly enhance the inflammatory and granulomatous response in animals receiving complete Freund's adjuvant (8, 34) . Enhancement of inflammation correlates with increased lymphokine/cytokine production by T cells after antigenic stimulation (8, 34) .
The exact relationship among the various immunopotentiating activities ofPTX and its role in eliciting EAE and EAO is unknown, but the results of our mapping studies raise several intriguing possibilities, particularly as they relate to candidate. genes located in the same region. These genes include Igk, Ly-2, Ly-3, 11-Sr [gene encoding interleukin 5 receptor], Ly-35, Ly4, and Tnfr-2 [gene encoding tumor necrosis factor (Tnf) receptor 21 (35, 36) . At present, our mapping data are inadequate to identify which, if any, of these candidate genes is related to the Bphs locus. The likelihood that any of these genes are important in susceptibility to EAE and MS as well as EAO is related to its potential role in the immunopathology of the disease process. Preliminary data indicate that the Bphs locus may control the sensitivity of SJL/J mice to lymphokines/cytokines such as Tnf (unpublished observation from this laboratory). Thus, the mapping of both Tnfr-2 and Il-5r within the interval encoding Bphs and the apparent requirement for lymphokine/cytokine secretion (particularly Tnf) by encephalitogenic (37) and orchitogenic (K. S. K. Tung, personal communication) T-cell lines and clones may be more than mere coincidence. It is conceivable that T cells gain access to the CNS through a combination ofevents involving lymphokine/ cytokine secretion and the expression of a susceptible allele at the Bphs locus. The recent demonstration that entry into the CNS is a function of the activation state-i.e., lymphokine/cytokine secretion-of T cells rather than the nature of either the Tcr or major histocompatibility complex-encoded gene products supports this possibility (38) .
The importance of CD8 in the EAE process is shown by studies using transgenic mice bred to have two chromosomes bearing a nuli allele at the CD8 locus ("homozygous CD8 knockouts"). Such mice display less mortality but more relapses during the course of EAE (39) . Similarly, reduction of circulating CD8 cells by anti-CD8 antibody also increases the frequency of EAE relapse (26) . Finally, a statistically significant excess of an allotype at the Igk locus [Km(l)] was found among patients with the most severe form of MS (27) . It is striking that MS severity is associated with this marker; however, similar results were observed in a study on EAE using a rat BC1 population (28) . Formulating a hypothesis on the basis of action of Bphs in autoimmune disease susceptibility will be difficult unless we know its precise location and identity. It is clear that further investigation of these loci is needed to assess their individual impact on EAE and MS as well as EAO.
Chromosome 6 is of particular significance to autoimmune disease. The role of Tcrb as a genetic factor in susceptibility to EAE is currently surrounded in controversy (29, 30) . The same is true for Tcra (31, 32, 40 sibility that several genes on chromosome 6 may be involved in EAE and EAO susceptibility. Appropriate BC1 populations are currently being studied.
Homologous human loci for those residing within the interval including the Bphs locus reside on different chromosomes within appropriate syntenic groups (Fig. 1C) . These human chromosomal regions can now be considered as candidate gene regions for MS. Linkage analysis with available markers corresponding to the mouse loci should be carried out in MS multiplex families for which the Tcrb and Tcra genes have been typed (40, 43) .
